Literature DB >> 20175029

Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.

Morris Sherman1.   

Abstract

Hepatocellular carcinoma (HCC) is increasing in incidence in many countries, and is the most common cause of death in patients with cirrhosis. With regular surveillance, small early HCC lesions can be identified. An algorithm has been developed that allows for diagnosis of these lesions. Very early HCC lesions have high cure rates with appropriate treatment. If all these factors are in place most HCCs can be cured.

Entities:  

Mesh:

Year:  2010        PMID: 20175029     DOI: 10.1055/s-0030-1247128

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  147 in total

1.  Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?

Authors:  Federico Piñero; Fernando Rubinstein; Sebastián Marciano; Nora Fernández; Jorge Silva; Yanina Zambelo; Margarita Anders; Alina Zerega; Ezequiel Ridruejo; Carlos Miguez; Beatriz Ameigeiras; Claudia D'Amico; Luis Gaite; Carla Bermúdez; Carlos Rosales; Gustavo Romero; Lucas McCormack; Virginia Reggiardo; Luis Colombato; Adrián Gadano; Marcelo Silva
Journal:  Dig Dis Sci       Date:  2018-12-03       Impact factor: 3.199

2.  Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients.

Authors:  Peter Richardson; Zhigang Duan; Jennifer Kramer; Jessica A Davila; Gia L Tyson; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-07       Impact factor: 11.382

3.  Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008.

Authors:  Sean F Altekruse; Katherine A McGlynn; Lois A Dickie; David E Kleiner
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

4.  Role of operative therapy in non-cirrhotic patients with metastatic hepatocellular carcinoma.

Authors:  Victor Zaydfudim; Rory L Smoot; Clancy J Clark; Michael L Kendrick; Florencia G Que; Michael B Farnell; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2012-05-30       Impact factor: 3.452

5.  Early diagnosis of hepatocellular carcinoma by microRNAs: shining a light from the genome's "dark matter".

Authors:  Alejandro H Corvalan
Journal:  Dig Dis Sci       Date:  2012-11       Impact factor: 3.199

6.  Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development.

Authors:  Yasuto Takeuchi; Fusao Ikeda; Toshiya Osawa; Yasuyuki Araki; Kouichi Takaguchi; Youichi Morimoto; Noriaki Hashimoto; Kousaku Sakaguchi; Tatsuro Sakata; Masaharu Ando; Yasuhiro Makino; Shuji Matsumura; Hiroki Takayama; Hiroyuki Seki; Shintarou Nanba; Yuki Moritou; Tetsuya Yasunaka; Hideki Ohnishi; Akinobu Takaki; Kazuhiro Nouso; Yoshiaki Iwasaki; Kazuhide Yamamoto
Journal:  World J Hepatol       Date:  2015-09-08

Review 7.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

8.  Upper midline incision for liver resection.

Authors:  Seoung Hoon Kim; Young Kyu Kim
Journal:  HPB (Oxford)       Date:  2012-09-24       Impact factor: 3.647

Review 9.  Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure?

Authors:  Rafael S Pinheiro; Daniel R Waisberg; Lucas S Nacif; Vinicius Rocha-Santos; Rubens M Arantes; Liliana Ducatti; Rodrigo B Martino; Quirino Lai; Wellington Andraus; Luiz A C D'Albuquerque
Journal:  Transl Gastroenterol Hepatol       Date:  2017-08-29

10.  Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection.

Authors:  Ting-Jung Wu; Shih-Shin Chang; Chia-Wei Li; Yi-Hsin Hsu; Tse-Ching Chen; Wei-Chen Lee; Chau-Ting Yeh; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2015-12-11       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.